Concourse Financial Group Securities’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4637 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5692 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5682 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5710 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5716 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5658 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5546 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5431 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5241 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5230 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5041 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5056 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4963 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4990 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4865 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4715 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4583 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4466 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4285 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4168 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4166 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4115 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3886 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4107 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4048 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3928 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3618 |
|